Howard Hughes vs UDR
HHH and UDR side by side, both in miscellaneous investing. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How HHH and UDR compare
UDR is the larger company, worth 2.4 times as much as Howard Hughes ($11.6B against $4.8B).
On earnings, Howard Hughes is cheaper: it trades at 16.3× trailing earnings, against 23.0× for UDR.
Howard Hughes grew revenue faster over the last twelve months (34.0% versus 1.5% for UDR).
UDR keeps more of each dollar of sales as profit, with a net margin of 30.4% compared with 12.3% at Howard Hughes.
UDR pays a dividend yielding 4.0%; Howard Hughes does not pay one.
UDR scores higher on the StockData Score (15 against 10 for Howard Hughes), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | HHH | UDR |
|---|---|---|
| Size and price | ||
| Market cap | $4.8B | $11.6B |
| Share price | $80.66 | $36.07 |
| Change, 1 year | −6.1% | 4.0% |
| Change, 5 years | −4.4% | −35.2% |
| Beta (5Y) | 0.86 | 0.06 |
| Employees | 500 | 1,420 |
| StockData Score | ||
| Total score | 10 | 15 (better) |
| Valuation score | 5 | 5 |
| Growth score | 1 | 2 (better) |
| Performance score | 4 | 5 (better) |
| Health score | 0 | 0 |
| Dividend score | 0 | 3 (better) |
| Valuation | ||
| P/E | 16.3× (better) | 23.0× |
| P/S | 2.0× (better) | 6.8× |
| P/B | 1.2× (better) | 3.9× |
| EV/EBITDA | 3.1× (better) | 9.6× |
| PEG | – | 0.36 |
| Fair value | $109.00 | $53.32 |
| Margin of safety | 26.0% | 32.4% (better) |
| Growth | ||
| Revenue growth (TTM) | 34.0% (better) | 1.5% |
| Revenue growth, 5Y average | – | 6.6% |
| Net income growth (TTM) | 28.4% | 296% (better) |
| EPS growth (TTM) | 8.1% | 313% (better) |
| EPS growth, 5Y average | – | 41.4% |
| Profitability | ||
| Operating margin | 21.3% | 40.8% (better) |
| Net margin | 12.3% | 30.4% (better) |
| Return on equity | 7.7% | 16.7% (better) |
| Return on invested capital | 22.1% | 22.3% (better) |
| Financial health | ||
| Interest coverage | 2.9× | 3.6× (better) |
| Altman Z-score | 0.53 | 1.47 (better) |
| Piotroski F-score | 4 | 6 (better) |
| Dividends and buybacks | ||
| Dividend yield | – | 4.0% |
| Payout ratio | – | 109% |
| Years of dividend growth | – | 16 |
| Dividend growth, 5Y average | – | 3.8% |
| Buyback yield | – | 3.6% |
| Shareholder yield | 0.00% | 7.6% (better) |
| Ownership | ||
| Held by institutions | 90.6% | 105% |
| Held by insiders | 94.9% | 0.46% |
| Insider net buying, 12 months | $1.0M (better) | −$3.5M |
| Superinvestors holding | 1 | – |
| Short interest, % of float | 182% | 4.0% |
Go deeper
- HHH stock overview
- HHH income statement
- HHH valuation and score
- UDR stock overview
- UDR income statement
- UDR valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.